drugset / Trial / NCT00814931

Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males

NCT00814931 ↗

Phase 1 Completed 23 enrolled CeNeRx BioPharma Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the effects of CXB722 on neuroendocrine stress response and subjective reports related to mood and stress during and after experimentally induced stress among healthy young males.

Timeline

Start
2008-12
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject PIVAGABINE Small molecule 900 mg Oral

Indications